Literature DB >> 3292335

Alterations in mucosal content of colonic glycoconjugates in inflammatory bowel disease defined by monoclonal antibodies.

D K Podolsky1, D A Fournier.   

Abstract

The presence of several glycoconjugates in colonic mucosa of patients with inflammatory bowel disease was assessed through indirect immunofluorescent staining using a collection of 23 monoclonal antibodies directed against human colonic mucin glycoproteins (anti-HCM MAbs). Intensity and distribution of staining by three anti-HCM MAbs were significantly altered in mucosa from patients with ulcerative colitis (UC) (n = 14) when compared with normal tissue (n = 15) and with tissue from patients with Crohn's disease as well as other inflammatory disorders (n = 15). Staining by anti-HCM MAb 17, which binds to colonic mucin glycoprotein species IV and V, was absent or diminished in 86% of samples from patients with active UC in contrast to 14% of normal and disease control specimens. Reduction in anti-HCM MAb 17 staining was less marked in mucosal biopsy specimens from patients with UC lacking acute inflammatory activity (n = 8). In contrast to the apparent loss of the MAb 17-defined epitopes, staining with anti-HCM MAbs 10 and 22 was enhanced in UC tissue compared with normal and disease controls. Increased staining with MAb 10 was present in 93% of samples from UC patients demonstrating active inflammation. Increased MAb 10 staining was not apparent in noninvolved mucosa from UC patients, indicating that increased expression of the specified epitope is related to the acute inflammatory process. In contrast, indirect immunofluorescent staining with MAb 22 was apparent in both involved (78%) and uninvolved (67%) UC mucosa in contrast to normal and disease controls (less than 12%). In addition, staining with several other anti-HCM MAbs (MAbs 3, 11, 15) was modestly and variably diminished (14%-28%) in UC, Crohn's disease, and other inflammatory disorders. These findings demonstrate the presence of alterations in mucosal content of specific glycoconjugate structures in association with UC. Inflammatory processes may also result in broad changes in glycoconjugate determinants generally.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292335     DOI: 10.1016/0016-5085(88)90494-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

Review 1.  Colonic mucus and mucosal glycoproteins: the key to colitis and cancer?

Authors:  J M Rhodes
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

2.  Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis.

Authors:  R D Pullan; G A Thomas; M Rhodes; R G Newcombe; G T Williams; A Allen; J Rhodes
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

Review 3.  Goblet cell compound exocytosis in the defense against bacterial invasion in the colon exposed to ischemia-reperfusion.

Authors:  Joep Grootjans; Inca H Hundscheid; Wim A Buurman
Journal:  Gut Microbes       Date:  2013-03-31

Review 4.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

5.  Bradykinin modulates mucin secretion but not synthesis from an intestinal goblet cell line.

Authors:  C M Stanley; T E Phillips
Journal:  Agents Actions       Date:  1994-10

6.  Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer.

Authors:  P Gibson; O Rosella; R Nov; G Young
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

7.  Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions.

Authors:  Rodrigo Bibiloni; Eduardo J Schiffrin
Journal:  Int J Inflam       Date:  2010-09-29

8.  Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect.

Authors:  A Raouf; N Parker; D Iddon; S Ryder; B Langdon-Brown; J D Milton; R Walker; J M Rhodes
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

9.  Glycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects.

Authors:  H Morita; M G Kettlewell; D P Jewell; P W Kent
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

10.  Immunolocalization and expression of kallistatin and tissue kallikrein in human inflammatory bowel disease.

Authors:  Antoni Stadnicki; Urszula Mazurek; Maciej Gonciarz; Danuta Plewka; Grazyna Nowaczyk; Joanna Orchel; Ezbieta Pastucha; Andrzej Plewka; Tadcusz Wilczok; Robert W Colman
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.